UNITED STATES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

October 21, 2009

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934

Research Frontiers Incorporated

File No. 001-09399 - CF#24133
_____________________

Research Frontiers Incorporated submitted an application under Rule 24b-2
requesting confidential treatment for information it excluded from the Exhibits to a Form
8-K filed on September 15, 2009.

Based on representations by Research Frontiers Incorporated that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:

Exhibit 10.51 through September 14, 2019

For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:



Maryse Mills-Apenteng
Special Counsel